Regenative Labs

• Stem Cell Therapies
• Tissue Allograft Processing

Regenative Labs is an FDA-registered manufacturer of amniotic membrane (AM) and umbilical cord tissue (UCT) allografts, produced under the FDA framework for minimally manipulated, homologous-use human tissue.

Founded by veteran industry professionals, Regenative Labs partners with physicians and surgery centers through an IRB-backed outcomes research program that gives clinicians transparent, real-world data on how UCT allografts perform in practice. The company has published more real-world UCT outcomes research than any other manufacturer in the category.

Regenative Labs' research team is committed to the principles of value-based care and outcomes tracking, and the company adheres to FDA and AATB guidelines. Learn more at www.regenativelabs.com.